Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|November 26, 2025
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging TrendsCassandra Catacalos-Goad, Charlotte Johnstone, Valery Z Grdzelishvili
Journal of Virology|April 11, 2025
METTL3 depletion blocks vesicular stomatitis virus replication in pancreatic cancer cells through the establishment of an intrinsic antiviral stateCassandra Catacalos-Goad, Jacob Hawkins, Quinton Krueger, et al.
Journal of Virology|February 3, 2026
Immunostimulatory nucleic acid nanoparticles establish antiviral state to inhibit viral infection and replicationMartin Panigaj, Cassandra Catacalos-Goad, Anh Ha, et al.
Molecular Therapy. Oncology|December 11, 2025
Fostamatinib (R788), a spleen tyrosine kinase inhibitor, sensitizes pancreatic cancer cells to oncolytic vesicular stomatitis virusCassandra Catacalos-Goad, Dakota W Goad, Molly C Holbrook, et al.
Pageof 1